Literature DB >> 8576476

Use of spirometry to predict risk of pneumothorax in CT-guided needle biopsy of the lung.

F García-Río1, J M Pino, J Casadevall, L Gómez, J M Atienza, S Díaz-Lobato, J Villamor.   

Abstract

OBJECTIVE: Our goal was to assess the usefulness of spirometry to estimate the risk of pneumothorax in patients undergoing percutaneous needle biopsy with CT guidance for solitary pulmonary nodule (SPN).
MATERIALS AND METHODS: We studied the results of 51 consecutive percutaneous needle biopsies with CT guidance for SPN obtained between 1988 and 1990. Forty-five men and six women, aged 65 +/- 11 (36-86) years, were included in the study. All biopsies were performed under CT guidance, with 90 mm 25G needles (0.5 mm thickness) fitted into luer-type syringes. The number of needle pass attempts never exceeded three. A spirometry before biopsy was performed in all patients.
RESULTS: Pneumothorax occurred in only 10 cases (19%). The patients with pneumothorax showed lower lesion size, forced vital capacity (FVC), forced expiratory volume (FEV1), and FEV1/FVC ratio. The contribution of these factors to pneumothorax was analyzed by a logistic regression model. The FEV1 was most strongly associated with the incidence of pneumothorax. We developed an equation for predicting the risk of this complication.
CONCLUSION: We conclude that decreasing FEV1 is associated with a higher pneumothorax rate.

Entities:  

Mesh:

Year:  1996        PMID: 8576476     DOI: 10.1097/00004728-199601000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  9 in total

1.  Guidelines for radiologically guided lung biopsy.

Authors:  A Manhire; M Charig; C Clelland; F Gleeson; R Miller; H Moss; K Pointon; C Richardson; E Sawicka
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

2.  Population-based estimates of transbronchial lung biopsy utilization and complications.

Authors:  Melissa H Tukey; Renda Soylemez Wiener
Journal:  Respir Med       Date:  2012-08-28       Impact factor: 3.415

3.  Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.

Authors:  Brian D Hobbs; Marilyn G Foreman; Russell Bowler; Francine Jacobson; Barry J Make; Peter J Castaldi; Raúl San José Estépar; Edwin K Silverman; Craig P Hersh
Journal:  Ann Am Thorac Soc       Date:  2014-11

4.  The results of computed tomography guided tru-cut transthoracic biopsy: complications and related risk factors.

Authors:  Fahri Halit Beşir; Remzi Altın; Levent Kart; Muhammed Akkoyunlu; Hüseyin Ozdemir; Tacettin Ornek; Sadi Gündoğdu
Journal:  Wien Klin Wochenschr       Date:  2011-02-17       Impact factor: 1.704

Review 5.  [Percutaneous thermoablation of lung metastases. Indication, performance, initial results, and imaging findings].

Authors:  C Weigel; S Schuchmann; M Kirsch; B Mensel; N Hosten
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

Review 6.  Ultrathin needle (25 G) aspiration lung biopsy: diagnostic accuracy and complication rates.

Authors:  Anastasia Oikonomou; Frederick R Matzinger; Jean M Seely; Carole J Dennie; Peter J Macleod
Journal:  Eur Radiol       Date:  2003-10-09       Impact factor: 5.315

7.  [Percutaneous laser-induced thermotherapy of lung metastases: experience gained during 4 years].

Authors:  C Weigel; M Kirsch; B Mensel; U Nerger; N Hosten
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

Review 8.  Modern diagnostic and therapeutic interventional radiology in lung cancer.

Authors:  Wai-Kit Lee; Eddie W F Lau; Kwang Chin; Oliver Sedlaczek; Karin Steinke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

9.  The role of clinical characteristics and pulmonary function testing in predicting risk of pneumothorax by CT-guided percutaneous core needle biopsy of the lung.

Authors:  Chunhai Li; Dexiang Wang; Fengxia Yang; Yang Song; Xuejuan Yu; Bo Liu; Haipeng Jia; Wei Zhou
Journal:  BMC Pulm Med       Date:  2021-08-06       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.